European Journal of Contraception and Reproductive Health Care

Papers
(The TQCC of European Journal of Contraception and Reproductive Health Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Correction100
A pioneer of hormonal contraception: Joseph W. Goldzieher54
Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999–2015 Zimbabwe Demographic Health Survey47
How often is oral contraception used for contraception? The need of benefit’s formalisation34
The use of long-acting and permanent contraceptive methods (LAPMs) among women who have completed childbearing in Indonesia: does informed choice matter?29
Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort15
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]15
Migration and newborn screening: time to build on the European Asylum, Integration and Migration Fund?14
The demand for family planning to limit childbearing satisfied with female permanent contraception in Sub-Saharan Africa: a meta-analysis of demographic and health surveys13
The prolonged-release oral formulations: a new era in hormonal contraception technology?13
Investigating barriers to effective contraceptive use in Sub-Saharan Africa and addressing associated challenges11
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial throm11
The far-reaching impact of abortion bans: reproductive care and beyond10
Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks’ gestation: a case series and systematic review of the literature10
Factors affecting age at menopause and their relationship with ovarian reserve: a comprehensive review9
Contraceptive switch and abandonment among women using the pill, condoms and injectables in Brazil9
Knowledge of contraceptive methods among deaf women: a qualitative study9
Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss9
Statement of Retraction [Can Porphyromonas gingivalis be a novel aetiology for recurrent miscarriage?]8
Conservative management of a viable cervical ectopic pregnancy with systemic and multiple local methotrexate injections. A case report8
Intervening factors in health care professionals’ attitudes and behaviours towards comprehensive abortion care in the workplace: a comparative case study of Tanzania and Ethiopia8
Perception of oral contraception – do women think differently from gynaecologists?8
Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods8
Women’s decision-making related to induced abortion – a cross sectional study during a period of Covid-19 pandemic, in Sweden7
The criminalisation of women’s healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes7
The preferences of women in Australia for the features of long-acting reversible contraception: results of a discrete choice experiment6
Sequential treatment with relugolix combination therapy in women with symptomatic uterine fibroids that were inadequately managed with 52 mg levonorgestrel intrauterine system: the first report6
Improvement of laboratory markers of anaemia in the treatment of heavy menstrual bleeding with a 19.5-mg intrauterine device: a pilot study6
“Better late than never but never late is better”, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis6
Statement of Retraction [Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial]6
Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure ® implant removal: a cross-sectional study6
Asked but not received: postpartum contraception access in opioid-using pregnant patients6
Narratives of men and women from the southeastern region of Brazil on some aspects of sexual and reproductive health, sexual life and contraception: a qualitative study5
Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder5
Advancing access, evidence, and equity in abortion care5
Pharmacist recommendations for emergency contraception in Belgium: a simulated user study5
Retraction5
The pre- Roe legal framework: a dissecting study of the evolution of abortion laws and their socio-legal implications5
Messaging and access strategies for improving emergency contraceptive knowledge and uptake among Italians5
The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain5
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction5
Does change in the shape of intrauterine contraceptive device Cu 375 and Cu T 380A affect the expulsion after post-partum insertion – a prospective randomized control trial5
Experiences and impacts of side effects among contraceptive users in the UK: exploring individual narratives of contraceptive side effects5
Abortion: legislation and statistics in Europe5
Retraction Notice5
Statement of Retraction: “Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users5
Ulipristal acetate for medical abortion: did we really need to create a ‘monster’?4
Impact of abortion bans on pregnancies with severe life-limiting foetal anomalies in the United States: a cost-effectiveness analysis4
Clinical improvement after Essure® devices removal: a systematic review4
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic4
Is women’s sexual function impaired by an abnormal pap smear?4
Access to abortion in a cross-border region in the Eastern Pyrenees: the case of Hospital de Cerdanya, between Spanish and French legislation4
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age – a systematic review4
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition4
Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives4
A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion4
We don´t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!4
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women4
Expression of Concern3
‘Do I want children later in life?’ Reproductive intentions of 1700 adolescents3
Depomedroxyprogesterone acetate impact on mifepristone action during medication abortion3
Views, attitudes and experiences of South Asian women concerning sexual health services in the UK: a qualitative study3
Contraception among HIV-positive women in Latvia- knowledge, experience and factors influencing the choice3
Medical termination of pregnancy: people’s expectations and experiences in the Netherlands3
Maternal polycystic ovary syndrome and the potential risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in the offspring: a systematic review and meta-analysis3
Detection of ectopic pregnancy and serum beta hCG levels in women undergoing very early medical abortion: a retrospective cohort study3
Knowledge, professional attitudes, and training among health professionals regarding male contraceptive methods3
Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours3
High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy3
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review3
Editors’ response3
Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients3
Legal abortion requests and outcomes for women when the law is restrictive – experience from a referral centre in south-eastern Brazil3
Usage of postpartum intrauterine contraceptive device (postpartum-IUD) after an increase in the institutional delivery rate in India: time to re-visit the effect of timing of counselling on its accept3
Onset and recovery from depressive mood changes on progestin treatment - a case series reporting the course and type of depressive symptoms in progestin users with different histories and risks3
Can transvaginal cervical length and cervical strain elastography predict mid-trimester medical induction to abortion intervals?3
From request to dispensation: how adolescent and young adult females experience access to emergency contraception in pharmacies3
Correction3
Intrauterine devices and gynaecological malignancies - an umbrella review of systematic reviews and meta-analyses3
0.38066697120667